A: Diamet (850 mg) is recommended for use in pregnancy with no risk of congenital malformations. It may also be beneficial in pregnant obese non-diabetic women (1✔✔Trusted Source Metformin for pregnancy and beyond: the pros and cons
A: Diamet (850 mg) is an effective weight-loss medication in insulin-sensitive and insulin-resistant overweight and obese patients. Diamet (850 mg) reduces calorie intake, which leads to weight loss in Non- Insulin Dependent Diabetes Mellitus (NIDDM) patients with obesity (2✔✔Trusted Source Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes
A: Diamet (850 mg) is used to treat metabolic comorbidities in women with polycystic ovary syndrome (PCOS), and it may also improve ovarian dysfunction (3✔✔Trusted Source Metformin in polycystic ovary syndrome: systematic review and meta-analysis
Q: What effect does Diamet (850 mg) have on the brain?
A: Diamet (850 mg) may lower the risk of cognitive decline in diabetic patients. In diabetic patients with depression, Diamet (850 mg) treatment improved cognitive function and produced antidepressant effects (4✔✔Trusted Source Metformin in the diabetic brain: friend or foe?
Q: What happens if alcohol is taken with Diamet (850 mg)?
A:Avoid alcohol intake with Diamet (850 mg), as it may increase the risk of lactic acidosis. Alcohol may affect blood glucose levels in diabetic patients (5✔✔Trusted Source Lactic acidosis in patients with diabetes
Medindia adheres to strict ethical publishing standards to provide accurate, relevant, and current health content. We source our material from reputable places such as peer-reviewed journals, academic institutions, research bodies, medical associations, and occasionally, non-profit organizations. We welcome and value audience feedback as a part of our commitment to health literacy and informed decision-making.
1. Metformin for pregnancy and beyond: the pros and cons - (https://pubmed.ncbi.nlm.nih.gov/34569082/# )
2. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes - (https://pubmed.ncbi.nlm.nih.gov/9526970/ )
3. Metformin in polycystic ovary syndrome: systematic review and meta-analysis - ( https://pubmed.ncbi.nlm.nih.gov/14576245/ )
4. Metformin in the diabetic brain: friend or foe? - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200667/ )
5. Lactic acidosis in patients with diabetes - (https://pubmed.ncbi.nlm.nih.gov/23299861/)
Search for Drugs/Medicines
Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:
Difference in GST/local taxes
Change in price by the company
Updation of price information may not have happened at the right time
For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does not intend to replace professional medical opinion in any manner whatsoever. Please also be aware that Medindia does not buy or sell medication.
Post a Comment
Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.